Alegre-Sanchez Adrian, Jiménez-Gómez Natalia, Moreno-Arrones Óscar M, Fonda-Pascual Pablo, Pérez-García Bibiana, Jaén-Olasolo Pedro, Boixeda Pablo
Dermatology Department, Laser Unit, Hospital Universitario Ramón y Cajal, Ctra Colmenar Viejo Km 9,100, 28034, Madrid, Spain.
Lasers Med Sci. 2018 Nov;33(8):1827-1831. doi: 10.1007/s10103-018-2459-z. Epub 2018 Feb 9.
The novel picosecond lasers, initially developed for faster tattoo removal, have also shown great efficacy in endogenous pigmentary disorders. To describe the efficacy and safety profile of an alexandrite (755-nm) picosecond laser in a wide range of pigmented flat and elevated cutaneous lesions. A retrospective study was performed in which we collected all the clinical images of patients treated with the 755-nm alexandrite picosecond laser for 12 months (November 2016-November 2017). Clinical features were obtained from their medical charts. Patients treated for tattoo removal were excluded. All the images were analyzed by three blind physicians attending to a visual analogue scale (VAS) from 0 to 5 (0, no change; 1, 1-24% clearance; 2, 25-49% clearance; 3, 50-74% clearance; 4, 75-99% clearance; 5, complete clearance). Patient satisfaction was obtained from a subjective survey including four items: very satisfied, satisfied, non-satisfied, and totally dissatisfied. Thirty-seven patients were included (12 males; 25 females). The mean age of the study was 42.35 years. Twenty-five patients (68%) were treated for different pigmented flat disorders such as solar and mucosal lentigines (5), stasis dermatitis (4), or nevus of Ota (4), among other diagnoses. Twelve patients (32%) were treated for epidermal elevated lesions such as warts (5), epidermal nevi (2), and seborrheic keratosis (3), among other elevated lesions. Mean number of laser treatment was 3.02 sessions while mean follow-up after last laser treatment was 4.02 months. Mean VAS score of the three observers was 3.44 (61% of clearance) for pigmentary flat disorders and 3.60 (67%) for elevated lesions. Adverse effects reported were mild blistering in the first 2-5 days following laser treatment in some of the patients. Overall satisfaction among the patients included was high. The novel 755-nm picosecond alexandrite laser is effective not only for the resolution of pigmented flat lesions of different nature but also for the treatment of the more difficult elevated pigmented lesions.
新型皮秒激光最初是为更快地去除纹身而开发的,在治疗内源性色素沉着疾病方面也显示出了显著疗效。为了描述翠绿宝石(755纳米)皮秒激光对各种色素沉着性扁平及隆起性皮肤病变的疗效和安全性。我们进行了一项回顾性研究,收集了2016年11月至2017年11月期间接受755纳米翠绿宝石皮秒激光治疗的所有患者的临床图像。从他们的病历中获取临床特征。排除因去除纹身而接受治疗的患者。所有图像由三名盲法医生根据0至5的视觉模拟量表(VAS)进行分析(0,无变化;1,清除1%-24%;2,清除25%-49%;3,清除50%-74%;4,清除75%-99%;5,完全清除)。通过一项主观调查获得患者满意度,该调查包括四个项目:非常满意、满意、不满意和完全不满意。纳入37例患者(男性12例;女性25例)。研究对象的平均年龄为42.35岁。25例患者(68%)接受了不同色素沉着性扁平疾病的治疗,如日光性和黏膜雀斑样痣(5例)、淤积性皮炎(4例)或太田痣(4例)等其他诊断。12例患者(32%)接受了表皮隆起性病变的治疗,如疣(5例)、表皮痣(2例)和脂溢性角化病(3例)等其他隆起性病变。平均激光治疗次数为3.02次,最后一次激光治疗后的平均随访时间为4.02个月。对于色素沉着性扁平疾病,三名观察者的平均VAS评分为3.44(清除率61%),对于隆起性病变为3.60(清除率67%)。报告的不良反应为部分患者在激光治疗后的头2至5天出现轻度水疱。纳入患者的总体满意度较高。新型755纳米皮秒翠绿宝石激光不仅对不同性质的色素沉着性扁平病变有效,而且对更难治疗的隆起性色素沉着病变也有效。